Skip to main content

Table 5 Mean pretreatment score values for global QOL and functional subscales compared between the present study and previous studies with available pretreatment data on patients with UM

From: Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma

EORTC QLQ-C30 scales

Present study, n = 118

Barker et al.

(2020), n = 200

Suchocka-Capuano et al.

(2011), n = 69

Van Beek et al.

(2018), n = 65

Global QOL

68.22 ± 08.96

76.1 ± 21.7

68.8 ± 19.3

76.4 ± 13.6

Physical functioning

93.01 ± 14.61

91.5 ± 17.0

89.7 ± 15.1

85.9 ± 19.6

Role functioning

83.62 ± 25.33

90.4 ± 21.5

82.4 ± 25.4

80.0 ± 29.1

Emotional functioning

64.27 ± 26.01

78.1 ± 20.2

75.4 ± 21.2

69.0 ± 22.7

Cognitive functioning

87.43 ± 17.42

87.8 ± 18.5

83.6 ± 18.6

80.8 ± 21.5

Social functioning

81.36 ± 24.57

90.6 ± 20.1

93.7 ± 15.2

92.6 ± 12.5

  1. QOL: quality of life; UM: uveal melanoma; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer QOL questionnaire